PIZZA, GENOVEFFA
 Distribuzione geografica
Continente #
NA - Nord America 289
EU - Europa 103
AS - Asia 49
AF - Africa 15
Totale 456
Nazione #
US - Stati Uniti d'America 280
IT - Italia 53
CN - Cina 39
NL - Olanda 22
CI - Costa d'Avorio 15
SE - Svezia 11
CA - Canada 9
FI - Finlandia 5
IE - Irlanda 4
SG - Singapore 4
VN - Vietnam 4
FR - Francia 3
DE - Germania 2
IN - India 2
UA - Ucraina 2
PL - Polonia 1
Totale 456
Città #
Chandler 72
Ashburn 25
Amsterdam 20
Napoli 19
Beijing 17
Millbury 13
Princeton 11
Des Moines 10
Ottawa 9
Boston 8
Nanjing 8
Naples 8
Dong Ket 4
Hebei 4
Lawrence 4
Nanchang 4
Seattle 4
Wilmington 4
Caserta 3
Houston 3
Los Angeles 3
Ann Arbor 2
Bari 2
Buffalo 2
Falls Church 2
Jiaxing 2
Messina 2
Philadelphia 2
Redwood City 2
Solaro 2
Torre Del Greco 2
Arezzo 1
Aversa 1
Changsha 1
Dearborn 1
Guangzhou 1
Landshut 1
Mumbai 1
Pagani 1
San Jose 1
Shenyang 1
Singapore 1
Tianjin 1
Washington 1
Totale 286
Nome #
Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women. 46
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 38
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 38
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 36
Open issues on G3 neuroendocrine neoplasms: Back to the future 32
Utilità della chirurgia bariatrica nel diabete mellito di tipo 2 31
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma? 31
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 30
The integrity of the Growth Hormone and Insuline-like Growth Factor -1 axis as outcome predictor after Laparoscopic Adjustable Silicone Gastric Banding. 29
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 29
The management of neuroendocrine tumours: A nutritional viewpoint 28
The safety of available treatments options for neuroendocrine tumors 27
Effect of the acute administration of the Dopamine Agonist Cabergoline on glucose tolerance and Insuline Sensitivity in patient with obesity. 26
Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any? 23
null 18
Prevalence of the Metabolic Syndrome in moderately-severely obese subjects with and without Growth Hormone Deficiency. 16
Totale 478
Categoria #
all - tutte 1.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202048 21 0 1 1 1 0 1 0 0 5 15 3
2020/202115 3 3 0 0 1 1 1 0 0 0 2 4
2021/2022123 0 0 22 3 4 13 1 1 5 5 32 37
2022/2023151 15 14 3 8 24 18 4 17 21 20 7 0
2023/202498 9 18 11 11 4 11 6 19 0 6 3 0
Totale 478